IDEAYA Biosciences, Inc. (IDYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.06B |
| Enterprise Value | 2.97B |
| P/E Ratio | -18.47 |
| PEG Ratio | -0.94 |
| Price/Sales Ratio | 14.62 |
| Price/Book Ratio | 2.72 |
| Enterprise/Revenue | 13.58 |
| Enterprise/EBITDA | -17.5 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.75 |
| Operating Margin | -0.93 |
AD
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -0.16 |
Income Statement
| Revenue | 218.71M |
| Revenue/Share | 2.54 |
| Gross Profit | -95.99M |
| EBITDA | -154.72M |
| Net Income | -113.7M |
| Diluted EPS | -1.28 |
Balance Sheet
| Total Cash | 828.96M |
| Total Cash/Share | 9 |
| Total Debt | 29.31M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 10.45 |
| Book Value Per Share | 13.02 |
Price History
| 52-Week Change | 23.85 |
| 52-Week High | 42.68 |
| 52-Week Low | 26.81 |
| Moving Average 50 Days | 37.77 |
| Moving Average 200 Days | 34.12 |
Statistics
| Average Volume | 793,276 |
| Shares Outstanding | 96.49M |
| % Held by Institutions | 111.91 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
